Kymera Therapeutics Inc (KYMR) Ownership

40.46 ↑0.29 (0.72%)
As of March 28, 2024, 12:10pm EST.

Institutional Ownership

Baker Bros Advisors LP is the biggest individual institutional holder of Kymera Therapeutics Inc (KYMR), owning a total of 6 million shares. Combined, the top 27 institutional holders of KYMR own 84.10% of the company with a total of 51 million shares.

In the latest ownership report on December 31st 2023, the top 27 institutional holders increased their combined ownership of KYMR by 3.1 million shares. 10 institutions bought 4,120,243 total additional shares and increased their ownership by an average of 78.56%. However 8 institutions sold 1,061,986 total shares and decreased their ownership by an average of 12.67%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Kymera Therapeutics increased by a net total of 3,058,257 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Baker Bros Advisors LP9.811%26.219%5,995,9281,245,5282023-12-31
T. Rowe Price Associates, Inc.8.731%5.503%5,335,712278,2872023-12-31
Wellington Management Company LLP7.880%-0.161%4,815,558-7,7712023-12-31
Vanguard Group Inc6.541%1.843%3,997,56472,3512023-12-31
venBio Select Advisor LLC6.177%-2.075%3,775,000-80,0002023-12-31
BlackRock Inc5.836%6.216%3,566,611208,7272023-12-31
Artal Group S A4.141%40.180%2,530,735725,3892023-12-31
State Street Corporation3.100%-4.613%1,894,279-91,6072023-12-31
Rock Springs Capital Management LP2.491%1.189%1,522,23817,8872023-12-31
Goldman Sachs Group Inc2.208%559.139%1,349,3101,144,6022023-12-31
T. Rowe Price Investment Management,Inc.2.121%-19.531%1,295,943-314,5532023-12-31
Aquilo Capital Management, LLC1.442%12.671%881,33799,1182023-12-31
Geode Capital Management, LLC1.441%5.549%880,51546,2882023-12-31
FMR Inc0.875%-38.590%534,600-335,9472023-12-31
Dimensional Fund Advisors, Inc.0.873%-18.544%533,723-121,5042023-12-31
JPMorgan Chase & Co0.838%-17.644%512,246-109,7462023-12-31
NORGES BANK0.825%127.047%504,083282,0662023-12-31
Massachusetts Financial Services Company0.757%-0.185%462,675-8582023-12-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Baker Bros Advisors LP9.811%26.219%5,995,9281,245,5282023-12-31
T. Rowe Price Associates, Inc.8.731%5.503%5,335,712278,2872023-12-31
Wellington Management Company LLP7.880%-0.161%4,815,558-7,7712023-12-31
Bvf Inc7.755%0.000%4,739,00402023-09-30
Vanguard Group Inc6.541%1.843%3,997,56472,3512023-12-31
venBio Select Advisor LLC6.177%-2.075%3,775,000-80,0002023-12-31
BlackRock Inc5.836%6.216%3,566,611208,7272023-12-31
Artal Group S A4.141%40.180%2,530,735725,3892023-12-31
State Street Corporation3.100%-4.613%1,894,279-91,6072023-12-31
Redmile Group, LLC3.058%0.000%1,868,50702023-09-30
Rock Springs Capital Management LP2.491%1.189%1,522,23817,8872023-12-31
Goldman Sachs Group Inc2.208%559.139%1,349,3101,144,6022023-12-31
T. Rowe Price Investment Management,Inc.2.121%-19.531%1,295,943-314,5532023-12-31
Bank of New York Mellon Corp1.747%-2.424%965,967-23,9992023-03-31
Aquilo Capital Management, LLC1.442%12.671%881,33799,1182023-12-31
Geode Capital Management, LLC1.441%5.549%880,51546,2882023-12-31
EcoR1 Capital, LLC1.437%0.000%796,09302023-03-31
Wasatch Advisors Inc.1.033%-52.232%572,907-626,4432023-09-30
FMR Inc0.875%-38.590%534,600-335,9472023-12-31
Dimensional Fund Advisors, Inc.0.873%-18.544%533,723-121,5042023-12-31
JPMorgan Chase & Co0.838%-17.644%512,246-109,7462023-12-31
NORGES BANK0.825%127.047%504,083282,0662023-12-31
Candriam Luxembourg S.C.A.0.823%0.000%488,30602023-09-30
Massachusetts Financial Services Company0.757%-0.185%462,675-8582023-12-31
AJU IB Investment Co Ltd0.828%0.000%457,05902022-09-30
Morgan Stanley - Brokerage Accounts0.732%24.388%405,90579,5832023-06-30
Northern Trust Corp0.605%-0.492%331,738-1,6402022-09-30

Mutual Fund Ownership

T. Rowe Price New Horizons is the biggest individual fund holder of Kymera Therapeutics Inc (KYMR), owning a total of 2.8 million shares. Combined, the top 34 mutual fund holders of KYMR own 40.50% of the company with a total of 24.2 million shares.

In the latest ownership report on February 29th 2024, the top 34 fund holders increased their combined ownership of KYMR by 36 thousand shares. 3 funds bought 41,933 total additional shares and increased their ownership by an average of 1.51%. However 4 funds sold 6,034 total shares and decreased their ownership by an average of 0.3%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Kymera Therapeutics increased by a net total of 35,899 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Total Stock Mkt Idx Inv2.225%0.000%1,359,51102024-02-29
SPDR® S&P Biotech ETF1.849%1.905%1,129,62221,1202024-02-29
Vanguard Small Cap Index1.826%0.940%1,116,08010,3902024-02-29
iShares Russell 2000 ETF1.511%-0.016%923,192-1512024-02-29
Vanguard Small Cap Growth Index Inv1.024%1.695%625,52910,4232024-02-29
Vanguard Institutional Extnd Mkt Idx Tr0.982%-0.634%600,141-3,8302024-02-29
iShares Biotechnology ETF0.605%-0.449%369,540-1,6652024-02-29
iShares Russell 2000 Growth ETF0.547%-0.116%334,081-3882024-02-29

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
T. Rowe Price New Horizons4.507%2.876%2,754,38276,9952023-12-31
US Small-Cap Growth II Equity Comp4.507%2.876%2,754,38276,9952023-12-31
Vanguard Health Care Inv2.360%0.000%1,442,01902023-12-31
Vanguard Total Stock Mkt Idx Inv2.225%0.000%1,359,51102024-02-29
Vanguard Instl Ttl Stck Mkt Idx Tr2.156%-0.117%1,196,248-1,3992023-03-31
SPDR® S&P Biotech ETF1.849%1.905%1,129,62221,1202024-02-29
Vanguard Small Cap Index1.826%0.940%1,116,08010,3902024-02-29
Vanguard Explorer Inv1.822%0.000%1,113,44502023-12-31
T. Rowe Price Health Sciences1.619%11.711%989,634103,7462023-12-31
iShares Russell 2000 ETF1.511%-0.016%923,192-1512024-02-29
Vanguard Small Cap Growth Index Inv1.024%1.695%625,52910,4232024-02-29
Vanguard Institutional Extnd Mkt Idx Tr0.982%-0.634%600,141-3,8302024-02-29
Vanguard Extended Market Index Investor0.973%-0.020%539,225-1102023-08-31
BNY Mellon Sm/Md Cp Gr I0.967%-2.257%534,574-12,3462023-04-30
Fidelity® Select Biotechnology0.959%-26.700%532,313-193,9002023-11-30
T. Rowe Price New Horizons Tr-Z0.756%4.203%461,91018,6322023-12-31
T. Rowe Price Small-Cap Value0.663%-36.098%404,853-228,7002023-12-31
UBS: US Equity Small Cap Growth0.656%0.000%401,10502023-09-30
Fidelity Select Biotechnology0.632%-27.403%386,441-145,8722024-01-31
iShares Russell 2000 Value ETF0.689%0.561%380,8642,1242023-06-21
Fidelity Small Cap Index0.620%1.259%378,8914,7122023-12-31
iShares Biotechnology ETF0.605%-0.449%369,540-1,6652024-02-29
Fidelity® Small Cap Index0.663%3.225%367,98211,4952023-10-31
T. Rowe Price Integrated US Sm Gr Eq0.582%0.000%355,70002023-12-31
TRP Integrated US Small-Cap Gr Eq0.641%23.080%355,70066,7002023-09-30
iShares Russell 2000 Growth ETF0.547%-0.116%334,081-3882024-02-29
Candriam Global Equities Oncology0.570%37.493%312,81585,3022022-09-30
Belfius Equities Cure C Cap0.570%0.000%312,81502022-10-31
T. Rowe Price U.S. SC Value Eq Tr-Z0.549%0.066%304,3452002023-09-30
DFA US Micro Cap I0.536%6.722%296,25818,6592023-05-31
Pictet-Biotech P USD0.530%-16.959%290,858-59,4012022-07-31
Fidelity Growth Compy Commingled Pl O0.473%0.000%289,017289,0172024-01-31
Wellington Global Hlthcr Eq USD G Ac0.460%41.092%281,02281,8452024-01-31
MFS New Discovery I0.469%0.000%278,52502023-12-31

Discussions

Please log in or register to share your thoughts.

unknownable

$KYMR wow
looking like it’s going to be a monster day!

0 Like Report
145zip

$KYMR Not Selling
Hodling for thousands!

0 Like Report